The effectiveness of smoking cessation interventions for socio-economically disadvantaged women: a systematic review and meta-analysis.
Behavioural
Cessation
Gender
Health disparities
Meta-analysis
Tobacco control
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
02 06 2022
02 06 2022
Historique:
received:
16
10
2020
accepted:
06
03
2022
entrez:
2
6
2022
pubmed:
3
6
2022
medline:
7
6
2022
Statut:
epublish
Résumé
This systematic review and meta-analysis assessed the effectiveness of smoking cessation interventions among women smokers in low socio-economic status (SES) groups or women living in disadvantaged areas who are historically underserved by smoking cessation services. A systematic literature search was conducted using MEDLINE (OVID), EMBASE, Cochrane, CINAHL, PsychINFO and Web of Science databases. Eligibility criteria included randomised controlled trials of any smoking cessation intervention among women in low SES groups or living in socio-economically disadvantaged areas. A random effects meta-analysis assessed effectiveness of interventions on smoking cessation. Risk of bias was assessed with the Cochrane Risk of Bias tool. The GRADE approach established certainty of evidence. A total of 396 studies were screened for eligibility and 11 (6153 female participants) were included. Seven studies targeted women-only. 5/11 tested a form of face-to-face support. A pooled effect size was estimated in 10/11 studies. At end of treatment, two-thirds more low SES women who received a smoking cessation intervention were more likely to stop smoking than women in control groups (risk ratio (RR) 1.68, 95% CI 1.36-2.08, I Behavioural and behavioural + pharmacotherapy interventions for smoking cessation targeting women in low SES groups or women living in areas of disadvantage were effective in the short term. However, longer follow-up periods indicated reduced effectiveness. Future studies to explore ways to prevent smoking relapse in this population are needed. PROSPERO: CRD42019130160.
Identifiants
pubmed: 35655281
doi: 10.1186/s13643-022-01922-7
pii: 10.1186/s13643-022-01922-7
pmc: PMC9164420
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
111Subventions
Organisme : Medical Research Council
ID : MR/S037519/1
Pays : United Kingdom
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : Health Research Board
ID : DIFA-2017-048
Pays : Ireland
Informations de copyright
© 2022. The Author(s).
Références
J Clin Epidemiol. 2011 Apr;64(4):401-6
pubmed: 21208779
HRB Open Res. 2019 Jun 12;2:10
pubmed: 32104776
BMJ Open. 2014 Dec 22;4(12):e006414
pubmed: 25534212
Tob Control. 2007 Dec;16(6):400-4
pubmed: 18048617
Nurs Res. 1988 Jul-Aug;37(4):196-201
pubmed: 3293024
J Clin Nurs. 2010 Apr;19(7-8):1102-12
pubmed: 20492055
Cochrane Database Syst Rev. 2017 Mar 31;3:CD001292
pubmed: 28361496
Lancet Public Health. 2019 Dec;4(12):e628-e644
pubmed: 31812239
Ann Emerg Med. 2015 Aug;66(2):140-7
pubmed: 25920384
Am J Public Health. 2000 May;90(5):786-9
pubmed: 10800431
JAMA Intern Med. 2019 Jun 1;179(6):777-785
pubmed: 31009023
Prev Med. 2016 Sep;90:170-6
pubmed: 27423320
J Am Coll Cardiol. 2016 Aug 23;68(8):777-85
pubmed: 27539168
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
N Engl J Med. 2014 Jan 2;370(1):60-8
pubmed: 24382066
Nicotine Tob Res. 2020 Apr 21;22(5):599-612
pubmed: 30715468
Prev Med. 2005 Mar;40(3):306-13
pubmed: 15533544
Addict Behav. 2011 Apr;36(4):315-9
pubmed: 21215528
BMJ. 2011 Mar 01;342:d1016
pubmed: 21363864
Prev Med. 2004 Jan;38(1):10-9
pubmed: 14672637
Prev Med. 2000 Jul;31(1):68-74
pubmed: 10896845
BMC Public Health. 2017 Nov 21;17(1):890
pubmed: 29162043
PLoS One. 2016 Jan 29;11(1):e0148194
pubmed: 26824352
Arch Pediatr Adolesc Med. 2003 Mar;157(3):295-302
pubmed: 12622686
Arch Intern Med. 2008 Oct 13;168(18):1950-60
pubmed: 18852395
J Epidemiol Community Health. 2006 Jan;60(1):7-12
pubmed: 16361448
N Engl J Med. 2008 Jun 5;358(23):2468-81
pubmed: 18525043
JAMA Intern Med. 2015 Feb;175(2):218-26
pubmed: 25506771
Ann Oncol. 2020 May;31(5):650-658
pubmed: 32321669
Tob Control. 2017 May;26(3):260-268
pubmed: 27122064
Cochrane Database Syst Rev. 2019 Sep 30;9:CD013183
pubmed: 31565800
BMJ Open. 2016 Jun 09;6(6):e011045
pubmed: 27288378
BMC Health Serv Res. 2006 Nov 06;6:147
pubmed: 17087825
Soc Sci Med. 2006 Dec;63(11):2791-800
pubmed: 16962221
Addiction. 2018 Oct;113(10):1905-1926
pubmed: 29749059
Cochrane Database Syst Rev. 2018 May 31;5:CD000146
pubmed: 29852054
Circulation. 1996 Feb 1;93(3):450-6
pubmed: 8565161
Nicotine Tob Res. 2010 Jul;12(7):756-62
pubmed: 20504946
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
CA Cancer J Clin. 2018 Mar;68(2):106-115
pubmed: 29384589
Addiction. 2011 Sep;106(9):1568-85
pubmed: 21489007
BMJ Open. 2019 Nov 11;9(11):e032449
pubmed: 31719091
Cochrane Database Syst Rev. 2019 Jun 05;6:CD009670
pubmed: 31166007
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Fam Pract. 2008 Oct;25(5):382-9
pubmed: 18689856
Am J Health Behav. 2019 Jan 1;43(1):50-56
pubmed: 30522566
Health Technol Assess. 2017 Jan;21(3):1-206
pubmed: 28121288
Addiction. 2012 Sep;107(9):1687-95
pubmed: 22372520
Eur J Cancer. 2010 Jan;46(2):405-11
pubmed: 19819687
Lancet. 2013 Jan 12;381(9861):133-41
pubmed: 23107252
Eur J Public Health. 2014 Aug;24(4):551-6
pubmed: 24891458
Compr Psychiatry. 2019 Nov;95:152125
pubmed: 31669972
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Health Stat Q. 2007 Summer;(34):26-34
pubmed: 17580645
BMJ. 2019 Jul 29;366:l4929
pubmed: 31358524
Pilot Feasibility Stud. 2019 Nov 23;5:138
pubmed: 31788324